254 TGF-beta blockade combined with activation-induced IL12 secretion synergize to optimize potency of MUC1-CAR T-cells in preclinical targeting of triple-negative breast cancer

• Laurent Poirot,
• Hana Cho,
• Piril Erler,
• Jordan Skinner,
• Beatriz Aranda-Orgilles

Affiliations

Laurent Poirot

2Cellectis, Paris, France

Hana Cho

1Cellectis, New York, NY, USA

Piril Erler

1Cellectis, New York, NY, USA

Jordan Skinner

1Cellectis, New York, NY, USA

Beatriz Aranda-Orgilles

1Cellectis, New York, NY, USA